PATENT CLAIM ANALYSIS

Application Number: 16014908
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "400000"]

Abstract:
There may be provided compositions of lipophilic pharmaceutical agents with improved solubility and stability. For example, there may be provided a non-aqueous composition that comprises a lipophilic pharmaceutical agent, and an amphiphilic polymeric solvent such as PEG400 but essentially free of organic solvents and non-solubilized particles. The composition may be further diluted with a desired aqueous diluent such as an infusion fluid for parenteral administration to a subject such as a human. The compositions may be useful for the treatment for diseases or conditions that are sensitive to lipophilic agents, such as infectious diseases, malignant or autoimmune diseases.

Claim (Index 22):
The solution of  claim 17 , wherein the volatile organic solvent is acidified.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.65625
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15451748', '13452033', '15154919', '13994152', '09415890']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8200132828110709
- 35 USC 102 Novelty (BERT): 0.5981535471484041
- Combined Prediction Score: 0.7978273092448043
- Mean Citation Score: 494.948404
- Max Citation Score: 640.89844
- Similarity Product: 428.38999541874887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test